Skip to content

Registry Study on the Impact of Allergen Immunotherapy on Growth and Development and Its Therapeutic Efficacy in Chinese Children and Adolescents with Mite-Induced Asthma Complicated with or without Allergic Rhinitis

Registry Study on the Impact of Allergen Immunotherapy on Growth and Development and Its Therapeutic Efficacy in Chinese Children and Adolescents with Mite-Induced Asthma Complicated with or without Allergic Rhinitis

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108059
Enrollment
Unknown
Registered
2025-08-25
Start date
2025-09-20
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

AIT Treatment Group:None

Sponsors

Shanghai Children’s Medical Center Comprehensive Pediatrics
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: (1) Age: 5 years = 0.70 (kU/L) (house dust mites and/or dust mites); meet either 2) or 3); (3) If allergic rhinitis is present, it should be evaluated as allergic rhinitis according to the ARIA guidelines.

Exclusion criteria

Exclusion criteria: (1) Patients with cognitive impairment or whose guardians cannot cooperate with treatment; (2) Patients with severe asthma or uncontrolled asthma (FEV1/FVC < 70%); (3) Patients using beta-blockers or angiotensin-converting enzyme (ACE) inhibitors; (4) Patients with malignant tumors, active severe infections or genetic metabolic diseases; (5) Patients with autoimmune deficiencies such as primary immunodeficiency or autoimmune diseases; (6) Pregnant adolescents or patients with severe endocrine diseases such as thyroid or growth hormone deficiency.

Design outcomes

Primary

MeasureTime frame
Height;Body weight;BMI;Evaluation of rhinitis control;

Secondary

MeasureTime frame
Anxiety and depression rating;sleep evalution ;medication assessment;Evaluation of asthma control;pulmonary function ;

Countries

China

Contacts

Public ContactWu Jinhong

Shanghai Children’s Medical Center Comprehensive Pediatrics

Wujinhong630@126.com+86 139 1711 4602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026